Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | CES2 | O00748 | 1/20 | 0.48 |
| ▸ | CES1 | P23141 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | DRD4 | P21917 | 1/20 | 0.43 |
| ▸ | ESR1 | P03372 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5449384 | 1.00 | ATM (0.54) | ATMSMN1; SMN2KMT2ACES2CES1 | |
| SCHEMBL14604957 | 1.00 | ATM (0.54) | ATMSMN1; SMN2KMT2ACES2CES1 | |
| SCHEMBL5450434 | 0.88 | PTGS2 (0.53) | ATMSMN1; SMN2KMT2ACES2CES1 | |
| SCHEMBL5450436 | 0.88 | PTGS2 (0.53) | ATMSMN1; SMN2KMT2ACES2CES1 | |
| SCHEMBL27348181 | 0.86 | KDM4E (0.57) | ATMSMN1; SMN2KMT2ACES2CES1 | |
| SCHEMBL10783630 | 0.84 | KDM4E (0.59) | ATMSMN1; SMN2CES2CES1MAPT | |
| SCHEMBL7418675 | 0.84 | KDM4E (0.59) | ATMSMN1; SMN2CES2CES1MAPT | |
| SCHEMBL7418674 | 0.84 | KDM4E (0.59) | ATMSMN1; SMN2CES2CES1MAPT | |
| SCHEMBL7924687 | 0.84 | KDM4E (0.59) | ATMSMN1; SMN2CES2CES1MAPT | |
| SCHEMBL5995590 | 0.84 | KDM4E (0.59) | ATMSMN1; SMN2CES2CES1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0557274-B1 | RECOVERY OF PALLADIUM | HENKEL CORP (US) | 1994-09-14 | — | — | EP | claimed |
| EP-0557274-A1 | RECOVERY OF PALLADIUM. | HENKEL CORP (US) | 1993-09-01 | — | — | EP | claimed |
| EP-0343791-B1 | STABILITY-IMPROVED TRIOXANE COMPOSITION | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1992-07-29 | — | — | EP | claimed |
| WO-1992008813-A1 | RECOVERY OF PALLADIUM | HENKEL CORPORATION (US) | 1992-05-29 | — | — | WO | claimed |
| US-5026875-A | Having ketoxime stabilizers; nondegradating, nonpolymerizing, formaldehyde-free | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1991-06-25 | — | — | US | claimed |
| EP-0343791-A1 | Stability-improved trioxane composition | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1989-11-29 | — | — | EP | claimed |
| US-10174033-B2 | N6-substituted adenosine derivatives and N6-substituted adenine derivatives and uses thereof | INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2019-01-08 | — | — | US | disclosed |
| US-8420679-B2 | Aminothiazole derivatives and their use as CRF receptor ligands | SANOFI (FR) | 2013-04-16 | — | — | US | disclosed |
| US-20130045942-A1 | N6-SUBSTITUTED ADENOSINE DERIVATIVES AND N6-SUBSTITUTED ADENINE DERIVATIVES AND USES THEREOF | INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2013-02-21 | — | — | US | disclosed |
| EP-2511283-A1 | N6-SUBSTITUTED ADENOSINE DERIVATIVES, N6-SUBSTITUTED ADENINE DERIVATIVES AND USES THEREOF | INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2012-10-17 | — | — | EP | disclosed |
| US-20070281919-A1 | Aminothiazole Derivatives And Their Use As CRF Receptor Ligands | SANOFI-AVENTIS (FR) | 2007-12-06 | — | — | US | disclosed |
| CN-1308294-C | Substituted acetophenone oxime derivative and preparation process and use thereof | SHANGHAI PESTICIDE INST (CN) | 2007-04-04 | — | — | CN | disclosed |
| EP-1242389-B1 | NOVEL BRANCHED SUBSTITUTED AMINO DERIVATIVES OF 3-AMINO-1-PHENYL-1H[1,2,4]TRIAZOL, METHODS FOR PRODUCING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | SANOFI SYNTHELABO (FR) | 2004-04-21 | — | — | EP | disclosed |
| WO-1992008813-A1 | RECOVERY OF PALLADIUM | HENKEL CORPORATION (US) | 1992-05-29 | — | — | WO | disclosed |
| US-5026875-A | Having ketoxime stabilizers; nondegradating, nonpolymerizing, formaldehyde-free | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1991-06-25 | — | — | US | disclosed |
| EP-0417167-A1 | PROCESS FOR THE SYNTHESIS OF O-SUBSTITUTED OXIME COMPOUNDS | AlliedSignal Inc. (US) | 1991-03-20 | — | — | EP | disclosed |
| WO-1989011473-A1 | PROCESS FOR THE SYNTHESIS OF O-SUBSTITUTED OXIME COMPOUNDS | ALLIED-SIGNAL INC. (US) | 1989-11-30 | — | — | WO | disclosed |
| EP-0343791-A1 | Stability-improved trioxane composition | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1989-11-29 | — | — | EP | disclosed |
| EP-0158159-B1 | PROCESS FOR THE SYNTHESIS OF O-SUBSTITUTED OXIME COMPOUNDS AND THE CONVERSION THEREOF INTO THE CORRESPONDING HYDROXYLAMINE O-SUBSTITUTED | AlliedSignal Inc. (US) | 1988-10-05 | — | — | EP | disclosed |
| EP-0158159-A1 | Process for the synthesis of o-substituted oxime compounds and the conversion thereof into the corresponding hydroxylamine o-substituted | AlliedSignal Inc. (US) | 1985-10-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070281919-A1 | Aminothiazole Derivatives And Their Use As CRF Receptor Ligands | CRH, CRHR1, CRHR2 | ATM 2013/4885SMN1; SMN2 4326/4885KMT2A 2839/4885 |
| US-10174033-B2 | N6-substituted adenosine derivatives and N6-substituted adenine derivatives and uses thereof | ADORA2A, ADORA3, ADORA1 | ATM 1162/4885SMN1; SMN2 330/4885KMT2A 373/4885 |
| US-20130045942-A1 | N6-SUBSTITUTED ADENOSINE DERIVATIVES AND N6-SUBSTITUTED ADENINE DERIVATIVES AND USES THEREOF | ADORA2A, ADORA3, ADORA1 | ATM 1162/4885SMN1; SMN2 330/4885KMT2A 373/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.